A phase 1, randomized, placebo-controlled, double-blind, multiple oral dose study of DS-8500a in Japanese healthy male subjects

Authors
Category Primary study
Registry of TrialsJapan Primary Registry Network
Year 2017
This article has no abstract
Epistemonikos ID: 6d10b9dc57a9e6d6799d4bf483424ecc0f47adf0
First added on: Apr 16, 2025